At this time, New York Oncology Hematology does not have access to acquire and administer the new COVID prophylaxis shot Evusheld for immunocompromised patients. We await further guidance from NYS and will keep our patients updated.

About Us

Dr. Ira Zackon Visits Capitol Hill to Advocate for Medicare Part B

4/02/2019

Ira Zackon, MD (NYOH), Barry Brooks, MD (TXO), Steve Paulson, MD (TXO), and Randy Broun, MD (OHC) met with Congressional members and staff on March 6 to highlight concerns with the Administration’s International Pricing Index (IPI) model. The US Oncology Network physicians advocated against specific provisions in the IPI model, primarily the insertion of third-party vendors in the procurement and administration of Part B drugs. 

The Network and other allied healthcare stakeholders have expressed numerous concerns about why the model could result in unintended consequences for patient access, outcomes, and overall costs.

To learn more, see Patient & Provider Concerns with the IPI Model.